P. Kwo

MAGELLAN-2: safety and efficacy of glecaprevir/pibrentasvir in liver or renal transplant adults with chronic hepatitis C genotype 1–6 infection

Nancy Reau, P. Kwo, Susan Rhee et al. · Journal of Hepatology · 2017 · 55 citations

Hepatology, Kidney Transplant, Hepatitis C +10

Interleukin 28B polymorphisms are the only common genetic variants associated with low‐density lipoprotein cholesterol (LDL‐C) in genotype‐1 chronic hepatitis C and determine the association between LDL‐C and treatment response

Paul J. Clark, A. Thompson, Mingyuan Zhu et al. · Journal of Viral Hepatitis · 2012 · 38 citations · Full text

P1232 SOFOSBUVIR AND RIBAVIRIN FOR THE TREATMENT OF RECURRENT HEPATITIS C INFECTION AFTER LIVER TRANSPLANTATION: RESULTS OF A PROSPECTIVE, MULTICENTER STUDY

Didier Samuel, Michael Charlton, Edward Gane et al. · Journal of Hepatology · 2014 · 24 citations

A Prospective, Transplantation, Hepatology +9

202 USE OF TELAPREVIR PLUS PEG INTERFERON/RIBAVIRIN FOR NULL RESPONDERS POST OLT WITH ADVANCED FIBROSIS/CHOLESTATIC HEPATITIS C

P. Kwo, Marwan Ghabril, Marcus Lacerda et al. · Journal of Hepatology · 2012 · 15 citations

Hepatic Disorders, Hepatology, Hepatitis C +8

100% SVR4 with ABT-493 and ABT-530 with or without Ribavirin in Treatment-Naïve HCV Genotype 3-Infected Patients with Cirrhosis

P. Kwo, David Wyles, S. Wang et al. · Journal of Hepatology · 2016 · 14 citations

Hepatology, Hepatitis C, Viral Hepatitis +7